Vanda Pharmaceuticals Competitors and Similar CompaniesClear all
Vanda Pharmaceuticals's competitors and similar companies include Supernus Pharmaceuticals, Assembly Biosciences, Corcept Therapeutics and Inotiv.
 Vanda Pharmaceuticals Vanda Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders. |  Supernus Pharmaceuticals Supernus Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system disorders. |  Assembly Biosciences Assembly Biosciences is a clinical stage biotechnology company which develops oral therapeutics for the treatment of hepatitis B virus infection and novel class of oral synthetic live biotherapeutics. |  Corcept Therapeutics Corcept Therapeutics is a company that specializes in the research and development of cortisol modulators. |  Inotiv Inotiv (formerly known as BioAnalytical Systems) provides research services to pharmaceutical and biotechnology companies. | |
Founding Date | Founding Date 2002 | Founding Date 2005 | Founding Date 2005 | Founding Date 1998 | Founding Date 1974 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Washington, US HQ Berlin, DE London, GB | Locations Rockville, US HQ | Locations South San Francisco, US HQ | Locations Redwood City, US HQ | Locations Indianapolis, US HQ |
Employees | Employees 2845% increase | Employees 6527% increase | Employees 11521% increase | Employees 35218% increase | Employees 2,099288% increase |
Valuation ($) | Valuation ($) 273.4 m | Valuation ($) 1.9 b | Valuation ($) 112.4 m | Valuation ($) 5 b | Valuation ($) 47.3 m |
Financial | |||||
Revenue (est.) | Revenue (est.) $198.8m (FY, 2024) | Revenue (est.) $661.8m (FY, 2024) | Revenue (est.) $28.5m (FY, 2024) | Revenue (est.) $675m (FY, 2024) | Revenue (est.) $490.7m (FY, 2024) |
Cost of goods | Cost of goods N/A | Cost of goods $77.9m (FY, 2024) | Cost of goods N/A | Cost of goods $10.9m (FY, 2024) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $583.9m (FY, 2024) | Gross profit N/A | Gross profit $664.2m (FY, 2024) | Gross profit N/A |
Net income | Net income ($18.9m) (FY, 2024) | Net income $73.9m (FY, 2024) | Net income ($40.2m) (FY, 2024) | Net income $141.2m (FY, 2024) | Net income ($108.9m) (FY, 2024) |
Funding | |||||
Total funding raised | Total funding raised $ 54m | Total funding raised $ 69.5m | Total funding raised N/A | Total funding raised $ 80.1m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Supernus Pharmaceuticals
HQ
Rockville, US
Employees
652↑ 7% increase
Supernus Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system disorders.
View companyAssembly Biosciences
HQ
South San Francisco, US
Employees
115↑ 21% increase
Assembly Biosciences is a clinical stage biotechnology company which develops oral therapeutics for the treatment of hepatitis B virus infection and novel class of oral synthetic live biotherapeutics.
View companyCorcept Therapeutics
HQ
Redwood City, US
Employees
352↑ 18% increase
Corcept Therapeutics is a company that specializes in the research and development of cortisol modulators.
View companyInotiv
HQ
Indianapolis, US
Employees
2,099
Inotiv (formerly known as BioAnalytical Systems) provides research services to pharmaceutical and biotechnology companies.
View company